NICE Technology Appraisals in Breast Oncology and the Impact on Cancer Treatment Unit Activity at the Sussex Cancer Network – 10-year Update

Purpose: The welcome development of new systemic anticancer therapies (SACT) has improved the clinical outcomes for people affected by breast cancer [1,2]. At present, 78% of cancer drug appraisal recommendations by NICE are positive [3]. We have reviewed how these changes have impacted visits to our SACT delivery units in the Sussex Cancer Network between 2013 and 2022.
Source: Clinical Oncology - Category: Radiology Authors: Source Type: research